| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_059babf90e455b4228aeb41f2eed9887 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05K999-99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/H05K999-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2019-09-09^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-02-01^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92141d19dd460dbdf7f89d2aaf919038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aa8c6c68a6ab6775cac0d7ad5890b97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10f23a75a83aee9c9e996ac0241ff51e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_855c96f27629e9dc49a590f7ce4312e2 |
| publicationDate |
2022-02-01^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-11235031-B2 |
| titleOfInvention |
Therapeutic dosing of a neuregulin or a subsequence thereof for treatment or prophylaxis of heart failure |
| abstract |
The invention relates to treatment of heart failure in a mammal. Accordingly, the invention is directed to establishing a dosing regimen whereby the therapeutic benefits conferred by administration of a neuregulin such as glial growth factor 2 (GGF2) or a subsequence thereof are maintained and/or enhanced, while concomitantly minimizing any potential side effects. |
| priorityDate |
2008-07-17^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |